Back To Rising Leaders Gallery
Kave Niksefat, one of In Vivo’s 2021 Rising Leaders, discussed his aspirations for Amgen, Inc.’s inflammation business and shared...
Amgen Is Still ‘A Biotech At Heart’
Exclusive Interview With Kave Niksefat
Head of Amgen’s inflammation business, Kave Niksefat, gives insight into how the 40-year-old biotech maintains its culture of innovation and avoids falling into the “trap” of bureaucracy.
